Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Genu Valgum

ClinicalTrials.gov lists 18 trials for Genu Valgum or a narrower condition beneath it. Zimmer Biomet has the most among industry and government lead sponsors, with 5.

MeSH D056304 Musculoskeletal Diseases C05
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Not applicable Not applicable 14 Observational Observational 4 Not applicable Not applicable 14 Observational Observational 4

Trials per phase

18 of the 18 trials are tagged with Genu Valgum itself; the rest are tagged with a narrower condition beneath it.

Get the Genu Valgum report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Genu Valgum trials start? (9)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Not applicable
  • Observational

Top of scale: 5

2009: 3 trials (Not applicable 3) 2014: 2 trials (Not applicable 2) 2018: 1 trials (Not applicable 1) 2019: 2 trials (Observational 1, Not applicable 1) 2020: 2 trials (Not applicable 2) 2021: 5 trials (Observational 3, Not applicable 2) 2023: 1 trials (Not applicable 1) 2025: 1 trials (Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2025 1
2023 1
2021 5
2020 2
2019 2
2018 1
2014 2
2009 3

No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 18 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Genu Valgum trials in? (2)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Not applicable 14
Observational 4

How many Genu Valgum trials are recruiting? (5)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 2
Active, not recruiting 2
Completed 9
Terminated 1
Unknown status 4

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Genu Valgum trials? (4)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Zimmer Biomet 5
Aesculap AG 1
Orthofix s.r.l. 1
Sorlandet Hospital HF 1

Which serious adverse events do Genu Valgum trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Contralateral Knee Replacement 4 1
Effusion/Swelling/Edema 4 1
KNEE PAIN 4 1
Stiffness/Limited ROM 4 1
TOTAL HIP JOINT REPLACEMENT 3 1

Which publications cover Genu Valgum? (10)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: drugs tested, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages